How many studies have been conducted on Chemokine Cxcl13?

BiohacksAI has indexed 226 PubMed studies on Chemokine Cxcl13, including 1 randomized controlled trials (RCTs). 51% of studies involve human subjects.

What are the main research areas for Chemokine Cxcl13?

The primary research domains for Chemokine Cxcl13 are 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation. This is based on analysis of 226 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Chemokine Cxcl13

A CXC chemokine that is chemotactic for B-LYMPHOCYTES. It has specificity for CXCR5 RECEPTORS.

226+ PubMed studies analyzed · 1 RCTs · Evidence Score: 51.5

Research Domains

Chemokine Cxcl13 has been studied across 18 research domains including 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation, 🫘 Kidney, ⏳ Longevity & Aging. The primary research focus is 🛡️ Immunity with 28% of studies addressing this area.

Loading evidence profile...

This evidence profile for Chemokine Cxcl13 is generated deterministically from 226 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.